Antiverse raises £3.5 M ($4.6 M) to advance generative AI antibody design platform

Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding.

Trial: ECMO Doesn’t Save Lives in Cardiogenic Shock

AMSTERDAM — Venoarterial extracorporeal membrane oxygenation (VA ECMO) didn’t improve survival with cardiogenic shock, the ECLS-SHOCK trial showed. This form of extracorporeal life support (ECLS)

August 28, 2023

Patients Demand Improved Healthcare Support, Hyro Survey Finds

What You Should Know: – A new survey conducted by Hyro, a healthcare AI-powered communications company, has revealed significant gaps in patient support within the

August 10, 2024

Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later

SAN DIEGO — Kids with sickle cell disease who underwent allogeneic stem cell transplantation (allo-SCT) had fewer serious disease complications along with better quality-of-life and

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.